{"id":"mcv-ac-vaccine-group","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or erythema"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains polysaccharide capsules from meningococcal serogroups A and C conjugated to a carrier protein, which enhances T-cell dependent immune responses and antibody production. This approach improves immunogenicity compared to unconjugated polysaccharide vaccines, particularly in younger populations, and provides protection against invasive meningococcal disease caused by these serogroups.","oneSentence":"MCV-AC is a meningococcal conjugate vaccine that stimulates immune responses against multiple serogroups of Neisseria meningitidis to prevent meningococcal disease.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:20:23.165Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A and C"}]},"trialDetails":[{"nctId":"NCT02003495","phase":"PHASE3","title":"Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine","status":"COMPLETED","sponsor":"Beijing Minhai Biotechnology Co., Ltd","startDate":"2013-10","conditions":"Meningitis","enrollment":2195}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Group A and C Meningococcal conjugate vaccine"],"phase":"phase_3","status":"active","brandName":"MCV-AC Vaccine Group","genericName":"MCV-AC Vaccine Group","companyName":"Beijing Minhai Biotechnology Co., Ltd","companyId":"beijing-minhai-biotechnology-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"MCV-AC is a meningococcal conjugate vaccine that stimulates immune responses against multiple serogroups of Neisseria meningitidis to prevent meningococcal disease. Used for Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A and C.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}